by | Jan 29, 2021 | Mitra, Robi, Moudgil, Arnav, Wilkinson, Michael Nathaniel
— Technology Description
Researchers in Robi Mitra’s lab at Washington University in St. Louis have developed a method to increase the sensitivity of leukemias to chemotherapy by pre-treatment with a BET inhibitor. BET inhibitors convert stem-like leukemia cells to a more differentiated state …
by | Nov 23, 2020 | Mitra, Robi, Moudgil, Arnav, Qi, Zongtai, Wilkinson, Michael Nathaniel
— Technology Description
Researchers in Prof. Rob Mitra’s laboratory have developed single cell calling cards (“scCCs”), a robust and versatile self-reporting transposon system for high throughput analysis of protein-DNA binding with single cell resolution. This technology simulta…
by | Nov 16, 2020 | Buchser, William, Lalli, Matthew, Milbrandt, Jeffrey, Mitra, Robi
— Technology Description
A team of Washington University researchers has developed a low-cost molecular diagnostics kit and reader that could provide rapid, widespread screening and surveillance for SARS-CoV-2 and other infections. This technology utilizes a reverse-transcription loop-mediated isot…
by | Sep 21, 2020 | Chen, Xuhua, Lalli, Matthew, Mitra, Robi, Moudgil, Arnav, Wilkinson, Michael Nathaniel
—
These plasmids can be used for single cell calling cards (“scCCs”), a robust and versatile self-reporting transposon system for high throughput analysis of protein-DNA binding with single cell resolution (WUSTL Technology T-018069). scCC simultaneously maps the precise location of tran…
by | Aug 21, 2020 | Mitra, Robi, Qi, Zongtai
— Chemically inducible PiggyBac transposase constructs. The plasmids that contain mutated destabilized domains, FKBP and DHFR, were purchased from Addgene with ID 31763 and 29326, respectively. The PBase-ERT2 plasmid (mPBase-L3-ERT2) was a kind gift from Dr. Allen Bradley . The coding sequence of mPBa…
by | Mar 10, 2018 | Corbo, Joseph, Havranek, James, Mitra, Robi, Myers, Connie, Qi, Zongtai, Zhang, Chi
— Background: The function of enzymes involved in homologous recombination can be exploited in the field of genetic engineering in order to generate mutations of interest. However, this machinery is not functionally efficient in post mitotic or terminally differentiated cells. Viral gene therapy techn…